Downregulation of pathogenic MICA-NKG2D interactions as a novel strategy in alopecia areata management: a new rationale for adjunct statin therapy?

J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1013-e1015. doi: 10.1111/jdv.18423. Epub 2022 Jul 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alopecia Areata* / drug therapy
  • Alopecia Areata* / pathology
  • Down-Regulation
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • NK Cell Lectin-Like Receptor Subfamily K / metabolism

Substances

  • NK Cell Lectin-Like Receptor Subfamily K
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Supplementary concepts

  • Diffuse alopecia